Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature-Reference-Cited by-同舟云学术

Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature

Published:2022-02 Issue: Volume:103 Page:102326
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Lombardi Pasquale,Rossini Daniele,Crespi Veronica,Germani Marco Maria,Bergamo Francesca,Pietrantonio Filippo,Santini Daniele,Allegrini Giacomo,Daniel Francesca,Pagani Filippo,Antoniotti Carlotta,Zaniboni Alberto,Conca Veronica,Latiano Tiziana Pia,Boccaccino Alessandra,Passardi Alessandro,Tamburini Emiliano,Masi Gianluca,Di Maio Massimo,Cremolini Chiara

Funder

University of Turin

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference31 articles.

1. Current cancer epidemiology;Mattiuzzi;J Epidemiol Glob Health,2019

2. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: Updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study;Cremolini;Lancet Oncol,2015

3. Individual patient data meta-analysis of folfoxiri plus bevacizumab versus doublets plus bevacizumab as initial therapy of unresectable metastatic colorectal cancer;Cremolini;J Clin Oncol,2020

4. Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer;Xu;OncoTargets Ther,2018

5. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer;Ferrara;Nat Rev Drug Discov,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcome of Colorectal Cancer Patients with Concomitant Hypertension: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2024-05-14

2. Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE;British Journal of Cancer;2024-02-12

3. Patterns and trends of mortality from metastatic colorectal cancer in Shanghai, China from 2005 to 2021: a population-based retrospective analysis;Journal of Cancer Research and Clinical Oncology;2024-02-02

4. Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival;Frontiers in Medicine;2023-01-23

5. The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers;Frontiers in Oncology;2022-09-29